BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20512278)

  • 1. Specific immunotherapy using Hymenoptera venom: systematic review.
    Watanabe AS; Fonseca LA; Galvão CE; Kalil J; Castro FF
    Sao Paulo Med J; 2010 Jan; 128(1):30-7. PubMed ID: 20512278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse reactions to venom immunotherapy.
    Ramirez DA; Londono S; Evans R
    Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy.
    Haeberli G; Brönnimann M; Hunziker T; Müller U
    Clin Exp Allergy; 2003 Sep; 33(9):1216-20. PubMed ID: 12956741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G; Sin BA; Misirligil Z
    J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venom immunotherapy in patients with allergic reactions to insect stings.
    Incorvaia C; Mauro M; Gritti BL; Makri E; Ridolo E
    Expert Rev Clin Immunol; 2018 Jan; 14(1):53-59. PubMed ID: 29202591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key Issues in Hymenoptera Venom Allergy: An Update.
    Alfaya Arias T; Soriano Gómis V; Soto Mera T; Vega Castro A; Vega Gutiérrez JM; Alonso Llamazares A; Antolín Amérigo D; Carballada Gonzalez FJ; Dominguez Noche C; Gutierrez Fernandez D; Marques Amat L; Martinez Arcediano A; Martinez San Ireneo M; Moreno Ancillo A; Puente Crespo Y; Ruiz Leon B; Sánchez Morillas L;
    J Investig Allergol Clin Immunol; 2017; 27(1):19-31. PubMed ID: 28211342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of venom immunotherapy on serum level of CCL5/RANTES in patients with Hymenoptera venom allergy.
    Gawlik R; Glück J; Jawor B; Rogala B
    Immunopharmacol Immunotoxicol; 2015; 37(4):375-9. PubMed ID: 26181651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in the diagnosis and treatment of hymenoptera venom allergy.
    Müller UR
    Int Arch Allergy Immunol; 2001 Apr; 124(4):447-53. PubMed ID: 11340327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venom immunotherapy for preventing allergic reactions to insect stings.
    Boyle RJ; Elremeli M; Hockenhull J; Cherry MG; Bulsara MK; Daniels M; Oude Elberink JN
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD008838. PubMed ID: 23076950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunotherapy against hymenoptera venom: report of ten patients].
    Guzmán M MA; Salinas L J; Toche P P; Marinovic M MA; Gallardo O AM
    Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insect venom allergy: diagnosis and treatment.
    Valentine MD
    J Allergy Clin Immunol; 1984 Mar; 73(3):299-304. PubMed ID: 6366028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Honeybee and wasp venom allergy: Sensitization and immunotherapy.
    Adib-Tezer H; Bayerl C
    J Dtsch Dermatol Ges; 2018 Oct; 16(10):1228-1247. PubMed ID: 30300499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining Discordant Serum IgE and Skin Testing Improves Diagnostic and Therapeutic Accuracy for Hymenoptera Venom Hypersensitivity Immunotherapy.
    Park HJ; Brooks DI; Chavarria CS; Wu RL; Mikita CP; Beakes DE
    J Allergy Clin Immunol Pract; 2022 Mar; 10(3):837-843.e3. PubMed ID: 34534718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agreement of skin test with IL-4 production and CD40L expression by T cells upon immunotherapy of subjects with systemic reactions to Hymenoptera stings.
    Urra JM; Cabrera CM; Alfaya T; Feo-Brito F
    Mol Immunol; 2016 Feb; 70():134-9. PubMed ID: 26774053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sting challenge test in Hymenoptera venom allergy: pros and cons.
    Bilò MB; Brianzoni MF; Garritani MS; Antonicelli L; Farabollini B; Bonifazi F
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):377-81. PubMed ID: 14768522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of hypersensitivity to hymenoptera venom.
    Roers A; Hunzelmann N
    Expert Opin Biol Ther; 2005 Oct; 5(10):1349-58. PubMed ID: 16197340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety.
    Müller U; Helbling A; Berchtold E
    J Allergy Clin Immunol; 1992 Feb; 89(2):529-35. PubMed ID: 1740583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients.
    Fricker M; Helbling A; Schwartz L; Müller U
    J Allergy Clin Immunol; 1997 Jul; 100(1):11-5. PubMed ID: 9257781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy and biologicals for the treatment of allergy to Hymenoptera stings.
    Ridolo E; Pellicelli I; Kihlgren P; Nizi MC; Pucciarini F; Senna G; Incorvaia C
    Expert Opin Biol Ther; 2019 Sep; 19(9):919-925. PubMed ID: 31190572
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk assessment of Hymenoptera re-sting frequency: implications for decision-making in venom immunotherapy.
    von Moos S; Graf N; Johansen P; Müllner G; Kündig TM; Senti G
    Int Arch Allergy Immunol; 2013; 160(1):86-92. PubMed ID: 22948338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.